Mice with human livers make pharmaceutical testing more accurate

July 12, 2011 by Deborah Braconnier report
Lab mice

(Medical Xpress) -- In a new report published in the Proceedings of the National Academy of Sciences, a team of researchers reveal a new miniature artificial human liver that can be implanted into mice to better enable testing of new drugs and how humans will metabolize them.

When it comes to pharmaceutical research, using mice to test drugs has had its limitations because the of a mouse reacts differently than a human liver. Scientists have been able to make a mouse liver more human-like by injecting into immunodeficient mice with damaged livers.

This new artificial human liver was developed by a team from Massachusetts Institute of Technology and led by biomedical engineer Sangeeta Bhatia. The miniature liver measures 20 millimeters and is implanted into healthy mice.

The human ectopic artificial livers, or HEALS as they call them, are created by co-culturing primary human hepatocytes, or human liver cells, with stabilizing mouse fibroblasts. These cells are then encapsulated using liver and a polymeric scaffold.

The researchers are able to adjust the pore size of the polymer in order to prevent access by the mouse immune system which then allows weeks of testing before possible rejection begins.

The researchers tested the new liver by giving the mice drugs which are metabolized differently by humans and mice such as coumarin (an anticoagulant) and debrisoquine (an antihypertensive). When the mice with the artificial livers received these drugs, they produced metabolites and showed the same metabolic interactions that are normally found in humans.

Current clinical testing of on humans results in 90 percent of drugs failing. This is often due to toxixities that were not discovered in animal preclinical because of the difference in how the mouse liver metabolizes the drug. Researchers hope this new technology will aid in making drug testing safer and discovering these toxicities before they ever get to human clinical trials.

More information: Humanized mice with ectopic artificial liver tissues, PNAS, Published online before print July 11, 2011, doi: 10.1073/pnas.1101791108

Abstract
“Humanized” mice offer a window into aspects of human physiology that are otherwise inaccessible. The best available methods for liver humanization rely on cell transplantation into immunodeficient mice with liver injury but these methods have not gained widespread use due to the duration and variability of hepatocyte repopulation. In light of the significant progress that has been achieved in clinical cell transplantation through tissue engineering, we sought to develop a humanized mouse model based on the facile and ectopic implantation of a tissue-engineered human liver. These human ectopic artificial livers (HEALs) stabilize the function of cryopreserved primary human hepatocytes through juxtacrine and paracrine signals in polymeric scaffolds. In contrast to current methods, HEALs can be efficiently established in immunocompetent mice with normal liver function. Mice transplanted with HEALs exhibit humanized liver functions persistent for weeks, including synthesis of human proteins, human drug metabolism, drug–drug interaction, and drug-induced liver injury. Here, mice with HEALs are used to predict the disproportionate metabolism and toxicity of “major” human metabolites using multiple routes of administration and monitoring. These advances may enable manufacturing of reproducible in vivo models for diverse drug development and research applications.

Related Stories

Recommended for you

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

New breast cell types discovered by multidisciplinary research team

November 20, 2017
A joint effort by breast cancer researchers and bioinformaticians has provided new insights into the molecular changes that drive breast development.

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.